Feedback / Questions
NI-071 (infliximab biosimilar) - Sanofi, Nichi-Iko, Binex, Aprogen
GS071: BLA submission in 2019
(Nichi-Iko Pharmaceutical Co., Ltd.)
-
Nov 30, 2017 -
Q2 FY2017 Results: US approval in FY2020
BLA
•
Biosimilar
http://nichiiko-ir.irbridge.com/en/PressRelease/PressRelease-5032602047476309106/main/0/link/4541_Presentation_E-1.pdf
Nov 30, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious